Age as a predictive factor in glioblastomas: Population-based study

Neuroepidemiology

Volumn 33, Issue 1, 2009, Pages 17-22

  Kita, Daisuke ^a   Ciernik, Ilja F ^b   Vaccarella, Salvatore ^a   Franceschi, Silvia ^a   Kleihues, Paul ^b   Lütolf, Urs M ^b   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Age; Glioblastoma; Population based study; Radiotherapy; Survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PROGNOSIS; SURVIVAL RATE; SWITZERLAND;

ADULT; AGE DISTRIBUTION; AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS;

EID: 62949099350     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210017     Document Type: Article

References (19)

1. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-1329.
2. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and metaanalysis of individual patient data from 12 randomised trials. Lancet 2002;359:1011-1018.
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987-996.
4. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85:704-710.
5. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993;26:239-244.
6. Burger PC, Green SB: Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 1987; 59:1617-1625.
7. Salmon I, Dewitte O, Pasteels JL, Flament Dur a nd J, Brotchi J, Vereerst raeten P, K iss R: Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type. J Neurosurg 1994;80:877-883.
8. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lutolf UM, Kleihues P: Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004;64:6892-6899.
9. Ohgaki H, Kleihues P: Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005;64:479-489.
10. Kleihues P, Cavenee WK: Pathology and Genetics of Tumours of the Nervous System. Lyon, IARC, 2000.
11. Lowry JK, Snyder JJ, Lowry PW: Brain tumors in the elderly: recent trends in a Minnesota cohort study. Arch Neurol 1998;55: 922-928.
12. Lefranc F, Sadeghi N, Camby I, Metens T, Dewitte O, Kiss R: Present and potential future issues in glioblastoma treatment. Expert Rev Anticancer Ther 2006;6:719-732.
13. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, Guillamo JS, Jadaud E, Colin P, Bondiau PY, Menei P, Loiseau H, Bernier V, Honnorat J, Barrie M, Mokhtari K, Mazeron JJ, Bissery A, Delattre JY: Radiotherapy for glioblastoma in the elderly. N Engl J Med 2007;356:1527-1535.
14. Halperin EC: Malignant gliomas in older adults with poor prognostic signs: getting nowhere, and taking a long time to do it. Oncology (Williston Park) 1995;9:229-234.
15. Ohga ki H, Kleihues P: Epidemiology and etiology of gliomas. Acta Neuropathol 2005;109: 93-108.
16. Werner MH, Phuphanich S, Lyman GH: The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer 1995;76: 1634-1642.
17. Fleury A, Menegoz F, Grosclaude P, Daures JP, Henry-Amar M, Raverdy N, Schaffer P, Poisson M, Delattre JY: Descriptive epidemiology of cerebral gliomas in France. Cancer 1997;79:1195-1202.
18. Polednak AP: Interpretation of secular increases in incidence rates for primary brain cancer in Connecticut adults, 1965-1988. Neuroepidemiology 1996;15:51-56.
19. Barker FG, Simmons ML, Chang SM, Prados MD, Larson DA, Sneed PK, Wara WM, Berger MS, Chen P, Israel MA, Aldape KD: EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001;51:410-418.